# Effects of Oral Sodium Bicarbonate Supplementation in Haemodialysis Patients (BicHD)

> **NCT02692378** · PHASE4 · COMPLETED · sponsor: **Imperial College Healthcare NHS Trust** · enrollment: 44 (actual)

## Conditions studied

- End-stage Renal Disease

## Interventions

- **DRUG:** sodium bicarbonate 500mg capsules

## Key facts

- **NCT ID:** NCT02692378
- **Lead sponsor:** Imperial College Healthcare NHS Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2016-10-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02692378

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02692378, "Effects of Oral Sodium Bicarbonate Supplementation in Haemodialysis Patients (BicHD)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02692378. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*